Skip to content

Is Ozempic Changing the Restaurant Industry?!?

The Chef's Cut

Hosted by Adrienne Cheatham and Joe Flamm

28m
Transcript

Original podcast

Summary

Written by a model from the transcript; not yet reviewed.

This episode of The Chef's Cut features hosts Joe Flamm and Adrienne Cheatham discussing the impact of GLP-1 medications like Ozempic and Mounjaro on the restaurant industry and dining habits. The hosts examine survey data from the National Restaurant Association showing that people taking these drugs continue to go out to eat regularly while ordering smaller portions, higher protein counts, and fewer alcoholic drinks. While quick-service chains scramble to introduce smaller portions and protein-focused menu items, fine dining and chef-driven restaurants find themselves less disrupted because their clientele treats dining out as an occasional indulgence. Ultimately, the hosts express optimism that people feeling healthier and more confident will drive increased socialization and vibrant restaurant culture.

  • Data shows that people using GLP-1 medications go out to eat just as frequently, or slightly more often, than those who do not use them. 9:01
  • Restaurants are adapting to changing consumer habits by expanding non-alcoholic beverage options, small plates, and high-protein dishes. 12:38
  • Unlike previous dietary movements such as Atkins or paleo, GLP-1 usage does not leave obvious, telltale modification requests on kitchen tickets. 23:27

Chapters

  1. 0:14
    Podcast Intro and Quick Pitch

    Hosts introduce the episode, ask listeners to rate the show, and set up the main topic of Ozempic’s impact on restaurants.

  2. 0:53
    Defining Ozempic and Its Restaurant Relevance

    The hosts explain what Ozempic is, how it works, and why chefs and restaurateurs are paying attention to it.

  3. 5:09
    Personal Experience: Mom’s Weight Loss Journey

    Joe shares his mother’s experience with Ozempic, highlighting weight loss, improved focus, and reduced inflammation.

  4. 6:00
    Chain vs. Chef-Driven Restaurants Response

    They compare how fast‑food chains quickly adapt menus while chef‑driven spots take a more measured approach.

  5. 9:01
    Survey Insights: Dining Frequency and Order Patterns

    The NRA survey shows Ozempic users dine out more often but choose different items, such as lighter options and fewer desserts.

  6. 10:00
    Strategic Menu Adjustments: Smaller Plates and Healthier Options

    Restaurants are offering smaller portions, high‑protein dishes, and non‑alcoholic beverages to meet changing demands.

  7. 24:55
    Future Outlook: Pills vs. Injections and Market Growth

    The hosts speculate on how the shift to oral pills and a growing user base may influence restaurant strategies.

  8. 28:21
    Closing Thoughts and Call to Action

    Hosts wrap up, encourage listener feedback, and remind listeners to subscribe and follow on social media.

Highlights

  • 1:33

    Exterior Industry Factorsinsight

    The guest points out that food trends are usually cooked up by chefs, whereas the Ozempic wave is an exterior factor that arrived unexpectedly but still profoundly impacts the restaurant industry.

  • 9:01

    NRA Survey Datadata

    Citing a National Restaurant Association survey from May, the host explains that individuals on GLP-1s actually go out to eat slightly more than non-users, but they alter what they order.

  • 11:11

    Special Occasion Dininginsight

    The guest argues that high-end, chef-driven restaurants do not need to overreact to trends because customers visit them for rare celebrations and date nights, planning to indulge fully.

  • 12:38

    Chain Reaction to Portionsstrategy

    Large casual chains like Olive Garden are responding to demand by offering smaller portions, such as a half-order of chicken parmesan with fewer calories.

  • 23:27

    Subtle Ticket Changesdebate

    The hosts debate how difficult it is to spot a diner on these medications because, unlike the Atkins or gluten-free eras, customers do not make bizarre, customized requests on kitchen tickets.

  • 25:52

    An Optimistic Outlookinsight

    The guest shares his hope that as these drugs help people feel and look better, they will feel more confident and eager to go out, socialize, and fill restaurants.

Quotes

  • “People who are on GLP-1s are going out to eat, on average, slightly more than people who are not on them.”
    Adrienne Cheatham · 9:01
  • “I want my friends to see me. I want to go on dates. I want to, you know, what I mean?”
    Joe Flamm · 26:09
  • “The number of shots of whiskey and cigarettes I've smoked, it's, I have no place to tell anybody.”
    Adrienne Cheatham · 6:28
  • “So it's like, they created the problem and now they're reacting to the problem.”
    Adrienne Cheatham · 14:39

About this episode

Adrienne and Joe dive into the Ozempic and GLP-1 trend to unpack its massive impact on the restaurant industry, shifting diner habits, and what it all means for the future of menus. In this episode, we also discuss: How shifting appetites change what we order, not how often How GLP-1s work and influence habits The demand for smaller portions and higher protein Who adapts faster: fast-casual or fine dining? Fewer desserts, less booze, and the mocktail boom Lessons from past diet trends like Atkins and Paleo Why feeling healthier might actually increase dining out How restaurants survive by constantly adapting Follow the show: @chefscutpod Follow Adrienne: @chefadriennecheatham Follow Joe: @insta.flamm

Transcript

0:00
28:46

5,621 words · 2 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • Ozempic
  • Olive Garden
  • GLP-1s
  • Slim Fast
  • Weight Watchers
  • Chipotle
  • Manjaro
  • TGI Fridays
  • Darden Restaurants
  • Subway

Page updated · transcript and summary are machine-generated